Terminally ill patients could benefit from stopping statins, study saysBMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h1620 (Published 23 March 2015) Cite this as: BMJ 2015;350:h1620
- Jacqui Wise
Discontinuing treatment with statins in patients with terminal illnesses is safe, could improve quality of life, and could reduce costs, US research published in JAMA Internal Medicine concludes.1
The pragmatic randomized trial looked at 381 patients with a mean age of 74.1 years. Half of the patients had cancer, and all had an estimated life expectancy of between one month and one year. The patients had been taking prescribed statins for three months or more for primary or secondary prevention of cardiovascular disease but had no recent active cardiovascular disease. Researchers randomized 189 …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial